Comparable responses of immunological markers in Japanese and European subjects after SQ HDM SLIT-tablet treatment

• Katsuyo Ohashi-Doi,
• Kaare Lund,
• Henrik Ipsen,
• Peter Sejr Andersen,
• Holger Mosbech,
• J. Christian Virchow,
• Minoru Kudo,
• Thomas Stranzl,
• Tomokazu Matsuoka

Affiliations

Katsuyo Ohashi-Doi

Torii Pharmaceuticals Co., Ltd., Tokyo, Japan; Corresponding author. Torii Pharmaceuticals Co., Ltd., 3-4-1 Nihonbashi-honcho, Chuo-ku, Tokyo 103-0023, Japan.

Kaare Lund

ALK-Abelló A/S, Hørsholm, Denmark; Papermill Medical, Ole Maaloes Vej 3, 2200, Copenhagen, Denmark

Henrik Ipsen

ALK-Abelló A/S, Hørsholm, Denmark

Peter Sejr Andersen

ALK-Abelló A/S, Hørsholm, Denmark

Holger Mosbech

Allergy Clinic, Copenhagen University Hospital, Gentofte, Denmark

J. Christian Virchow

University of Rostock, Rostock, Germany

Minoru Kudo

Torii Pharmaceuticals Co., Ltd., Tokyo, Japan

Thomas Stranzl

ALK-Abelló A/S, Hørsholm, Denmark

Tomokazu Matsuoka

University of Yamanashi, Yamanashi, Japan